Bazedoxifene/conjugated estrogens

Bazedoxifene/conjugated estrogens, sold under the brand name Duavee in the US and Duavive in the EU, is a fixed-dose combination medication for the treatment of menopause symptoms and postmenopausal osteoporosis.[2] It contains the selective estrogen receptor modulator bazedoxifene and conjugated estrogens. It is taken by mouth.

Bazedoxifene/conjugated estrogens
Combination of
BazedoxifeneSelective estrogen receptor modulator
Conjugated estrogensEstrogen
Clinical data
Trade namesDuavee, Duavive
AHFS/Drugs.comProfessional Drug Facts
MedlinePlusa614004
License data
Pregnancy
category
    Routes of
    administration
    By mouth
    ATC code
    Legal status
    Legal status
    • US: ℞-only
    • In general: ℞ (Prescription only)
    Identifiers
    ChemSpider
    • None
    KEGG

    The combination was approved for medical use in the United States in October 2013,[3] and in the European Union in December 2014.[4]

    Recall

    In June 2020, Pfizer recalled recalled two batches of Duavive, its oestrogen replacement product, as a result of concerns raised about faulty packaging.[5]

    gollark: xx:53:49. Autorefreshing starts at xx:51:49 this time.
    gollark: You just have to click "teleport" when the egg is about to die. Or a bit beforehand because of latency, I suppose. Or if it turns.
    gollark: <@&358173303816323072>
    gollark: My next experiment's at xx:53:49, can anyone catch?
    gollark: * so

    See also

    References


    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.